China Universal Asset Management Company’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$119K Buy
34,434
+431
+1% +$1.49K 0.01% 349
2025
Q1
$89.1K Sell
34,003
-1,488
-4% -$3.9K 0.01% 364
2024
Q4
$146K Buy
35,491
+9,740
+38% +$40.1K 0.01% 355
2024
Q3
$182K Buy
25,751
+10,157
+65% +$71.9K 0.02% 310
2024
Q2
$102K Sell
15,594
-9,616
-38% -$62.7K 0.01% 301
2024
Q1
$209K Buy
25,210
+10,953
+77% +$90.9K 0.03% 283
2023
Q4
$157K Buy
14,257
+11,122
+355% +$122K 0.03% 229
2023
Q3
$26.4K Buy
3,135
+1,541
+97% +$13K 0.01% 281
2023
Q2
$20K Sell
1,594
-50
-3% -$628 0.01% 268
2023
Q1
$27.1K Buy
1,644
+416
+34% +$6.85K 0.01% 192
2022
Q4
$18.3K Buy
1,228
+208
+20% +$3.11K 0.01% 181
2022
Q3
$23K Buy
+1,020
New +$23K 0.01% 148